2020
DOI: 10.1016/j.biopsych.2020.01.021
|View full text |Cite
|
Sign up to set email alerts
|

Glutamate and Dysconnection in the Salience Network: Neurochemical, Effective Connectivity, and Computational Evidence in Schizophrenia

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
36
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 63 publications
(40 citation statements)
references
References 55 publications
2
36
0
Order By: Relevance
“…Specifically, connectivity-neurotransmitter coupling has been proposed and observed in healthy populations (28,29). Similarly, network dysconnectivity in schizophrenia has been associated with altered neurotransmission (30,31) involving dopaminergic, serotonergic, gamma-aminobutyric acid (GABA)-ergic, and glutamatergic pathways (32)(33)(34)(35). Here, it is interesting to note that current anti-psychotic drugs mainly targeting the dopamine system are primarily effective against positive rather than negative or cognitive symptoms (36,37).…”
Section: Introductionmentioning
confidence: 99%
“…Specifically, connectivity-neurotransmitter coupling has been proposed and observed in healthy populations (28,29). Similarly, network dysconnectivity in schizophrenia has been associated with altered neurotransmission (30,31) involving dopaminergic, serotonergic, gamma-aminobutyric acid (GABA)-ergic, and glutamatergic pathways (32)(33)(34)(35). Here, it is interesting to note that current anti-psychotic drugs mainly targeting the dopamine system are primarily effective against positive rather than negative or cognitive symptoms (36,37).…”
Section: Introductionmentioning
confidence: 99%
“…Secondly, while the prevalence of C9ORF72 repeat expansion mutations is not known to be higher than expected among patients with schizophrenia, late onset cases (> 40 years of age) with family history of unknown degenerative illnesses or long-term psychiatric institutionalization should carry a low threshold for C9ORF72 evaluation. Third, we report an FDG-PET finding that shows striking hypometabolism in the Salience Network, a large-scale brain network that also has a critical role in the pathophysiology of schizophrenia [ 16 ], in addition to frontotemporal reduction characteristic of other variants of FTD. Of interest, bilateral insula, anterior cingulate cortex and thalamus constituting the Salience Network are also the most likely regions of grey matter reduction in schizophrenia [ 17 ].…”
Section: Discussionmentioning
confidence: 99%
“…From a neurobiological and neuropharmacological point of view, these results may implicate that the insular cortex represents a preferential site in which antipsychotics exert time-dependent effects, irrespective of the antipsychotic used. From a clinical point of view, the insular cortex has been considered a crucial region for the salience network, which is widely affected by dopaminergic and glutamatergic neurotransmission, and is involved in the ability to discriminate between self-generated and external information [74,75]. Alterations in the salience network and insula overactivations may underlie many of the clinical features of psychotic disorders [76,77].…”
Section: Discussionmentioning
confidence: 99%